Inhibition of oxidized low-density lipoprotein with orticumab inhibits coronary inflammation and reduces residual inflammatory risk in psoriasis: a pilot randomized, double-blind placebo-controlled trial is a research paper published in Cardiovascular Research (2024). On theSindex it has a DataRank of 1.0. It has been cited 30 times, with 27 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
Repositories this paper deposited data in (declared in PubMed).
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.515
From this paper's citation signal
Citation Network Contribution
0.486
From 21 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 27 citers.
British Heart Foundation
Grant: CH/F/21/90009 and RG/F/21/110040
British Heart Foundation
Grant: RG/F/21/110040
British Heart Foundation
Grant: CH/F/21/90009
NIH HHS
Research Oxford Biomedical Research Centre
Abcentra
National Institutes of Health
Research Oxford Biomedical Research Centre
Abcentra
NIH HHS
Fields of Study
MeSH Terms